Ankur Drugs and Pharma has informed that a meeting of the board of directors of the company will be held on August 14, 2012, to approve the un-audited financial results of the company for the quarter ended June 30, 2012 and to consider the appointment of A. K. Khadke, representative of Central Bank of India as nominee director on the board of directors of the company.
The above information is a part of company's filings submitted to BSE.